Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab - Fink, Anna-Maria; Böttcher, S.; Ritgen, M.; Fischer, K.; Pflug, N.; Eichhorst, B.; Wendtner, C.-M.; Winkler, D.; Bühler, A.; Zenz, Thorsten; Staib, P.; Mayer, J.; et al. (Leukemia, 2013)
Gesehen am 06.04.2021